The Correlation between Elevated HDL-Cholesterol, Body Mass Index, and Presence of Thyroid Nodules: A Retrospective Analysis
dc.contributor.author | Zorkun, Cafer | |
dc.contributor.author | Yalta, Kenan | |
dc.contributor.author | Eren, Alara | |
dc.contributor.author | Yetkin, Ertan | |
dc.date.accessioned | 2024-06-12T10:52:45Z | |
dc.date.available | 2024-06-12T10:52:45Z | |
dc.date.issued | 2023 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | Background: Elevated high-density lipoprotein-cholesterol (HDL-cholesterol) levels have been linked to unfavorable outcomes in various clinical settings, but the association with thyroid nodules remains unclear. We aimed to analyze the correlation between elevated HDL-cholesterol and the presence of thyroid nodules along with certain demographic and clinical findings. Methods: In this retrospective study, the patients were divided into three groups based on their body mass index (BMI): <25, 25-29, and >30 and evaluated. Data of 677 patients aged between 15 and 95 years (52.6 +/- 15.6) were evaluated. The entire study population comprised 516 females (76.2%). Results: Thyroid nodules (67.1%) and left ventricle diastolic dysfunction (LVDD) (58.1%) were the two most frequent findings in the overall cohort. In the multivariate regression model, BMI, heart rate, and HDL-cholesterol values were significant and independent predictors (p = 0.000 for all) of the presence of thyroid nodules. The presence of thyroid nodules is higher in females, particularly within the higher BMI groups [odds ratio (OR) = 1.048 (CI = 1.02-1.08) for BMI < 25, p = 0.003; OR = 1.094 (CI = 1.05-1.14) for BMI 25-29, p = 0.000; OR = 1.115 (CI = 1.05-1.19) for BMI >= 30]. This higher incidence is not observed in males. Conclusion: While the precise mechanisms underlying this association are yet to be fully elucidated, elevated HDL-cholesterol may serve as an indicator of thyroid nodules rather than a marker of cardiovascular protection. | en_US |
dc.identifier.doi | 10.3390/jcm12237411 | |
dc.identifier.issn | 2077-0383 | |
dc.identifier.issue | 23 | en_US |
dc.identifier.pmid | 38068463 | en_US |
dc.identifier.scopus | 2-s2.0-85179363008 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.uri | https://doi.org/10.3390/jcm12237411 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/18819 | |
dc.identifier.volume | 12 | en_US |
dc.identifier.wos | WOS:001117694200001 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Mdpi | en_US |
dc.relation.ispartof | Journal Of Clinical Medicine | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Atherosclerosis | en_US |
dc.subject | Cardiovascular Protection | en_US |
dc.subject | HDL-Cholesterol | en_US |
dc.subject | Body Mass Index | en_US |
dc.subject | Thyroid Nodules | en_US |
dc.subject | High-Density-Lipoprotein | en_US |
dc.subject | Dysfunctional Hdl | en_US |
dc.subject | Inflammation | en_US |
dc.subject | Association | en_US |
dc.subject | Management | en_US |
dc.subject | Mortality | en_US |
dc.title | The Correlation between Elevated HDL-Cholesterol, Body Mass Index, and Presence of Thyroid Nodules: A Retrospective Analysis | en_US |
dc.type | Article | en_US |